Sachdeva Sarbjot, Musayev Faik N, Alhamadsheh Mamoun M, Scarsdale J Neel, Wright H Tonie, Reynolds Kevin A
Department of Chemistry, Portland State University, Portland, OR 97207, USA.
Chem Biol. 2008 Apr;15(4):402-12. doi: 10.1016/j.chembiol.2008.03.007.
Mycobacterium tuberculosis FabH initiates type II fatty acid synthase-catalyzed formation of the long chain (C(16)-C(22)) acyl-coenzyme A (CoA) precursors of mycolic acids, which are major constituents of the bacterial cell envelope. Crystal structures of M. tuberculosis FabH (mtFabH) show the substrate binding site to be a buried, extended L-shaped channel with only a single solvent access portal. Entrance of an acyl-CoA substrate through the solvent portal would require energetically unfavorable reptational threading of the substrate to its reactive position. Using a class of FabH inhibitors, we have tested an alternative hypothesis that FabH exists in an "open" form during substrate binding and product release, and a "closed" form in which catalysis and intermediate steps occur. This hypothesis is supported by mass spectrometric analysis of the product profile and crystal structures of complexes of mtFabH with these inhibitors.
结核分枝杆菌FabH启动II型脂肪酸合酶催化形成分枝菌酸的长链(C(16)-C(22))酰基辅酶A(CoA)前体,分枝菌酸是细菌细胞壁的主要成分。结核分枝杆菌FabH(mtFabH)的晶体结构显示,底物结合位点是一个埋藏的、延伸的L形通道,只有一个溶剂进入入口。酰基辅酶A底物通过溶剂入口进入将需要底物以能量上不利的爬行方式穿入其反应位置。使用一类FabH抑制剂,我们测试了另一种假设,即FabH在底物结合和产物释放过程中以“开放”形式存在,而在催化和中间步骤发生时以“封闭”形式存在。该假设得到了对产物谱的质谱分析以及mtFabH与这些抑制剂复合物的晶体结构的支持。